Stephen A. Sherwin

Companies

• BiogenBoard member Mar 24, 2010 to now¹
• Neurocrine BiosciencesBoard member Jun 30, 2006 to now²
• Epiphany Technology Acquisition Corp.Board member Oct 4, 2022 to Oct 4, 2022³
• BioPlus Acquisition Corp.Board member Dec 2, 2021 to Dec 2, 2021⁴
• CHINOOK THERAPEUTICS, INC.Board member Jun 26, 2015 to May 28, 2020⁵
• RIGEL PHARMACEUTICALS INCBoard member Jun 1, 2006 to May 12, 2016⁶
• Verastem OncologyBoard member Mar 6, 2013 to Jun 16, 2015⁷
• Fresh Tracks Therapeutics, Inc.Board member May 28, 2013 to May 26, 2015⁸
• ANI PHARMACEUTICALS INCBoard member Oct 15, 2009 to Mar 30, 2012⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Biogen BIIB15,193 shares¹⁰$3.5M at $232.66Jun 9, 2026
• Neurocrine Biosciences NBIX14,860 shares¹¹$2.0M at $136.95Sep 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Gift 1,000 shares of Neurocrine Biosciences¹¹
• Jun 9, 2026Granted 1,505 shares of Biogen¹⁰
• Jun 5, 2026Sold 1,843 shares at $167.31 of Neurocrine Biosciences¹²
• Jun 5, 2026Sold 5,829 shares at $166.56 of Neurocrine Biosciences¹²
• Jun 5, 2026Sold 6,896 shares at $165.79 of Neurocrine Biosciences¹²
• Jun 5, 2026Sold 2,549 shares at $164.44 of Neurocrine Biosciences¹²
• Jun 5, 2026Sold 7,883 shares at $163.81 of Neurocrine Biosciences¹²
• Jun 5, 2026Exercised options 10,000 shares at $79.79 of Neurocrine Biosciences¹²
• Jun 5, 2026Exercised options 15,000 shares at $53.64 of Neurocrine Biosciences¹²
• May 21, 2026Exercised options 3,318 shares of Neurocrine Biosciences¹³
• Sep 2, 2025Gift 1,000 shares of Neurocrine Biosciences¹⁴
• Jun 17, 2025Granted 2,370 shares of Biogen¹⁵
• May 22, 2025Exercised options 2,869 shares of Neurocrine Biosciences¹⁶
• Mar 7, 2025Sold 8,760 shares at $150.02 of Biogen¹⁷
• Feb 13, 2025Sold 13,831 shares at $116.69 of Neurocrine Biosciences¹⁸
• Nov 4, 2024Gift 2,000 shares of Neurocrine Biosciences¹⁹
• Jun 21, 2024Granted 1,340 shares of Biogen²⁰
• May 29, 2024Sold 15,000 shares at $133.47 of Neurocrine Biosciences²¹
• May 29, 2024Exercised options 15,000 shares at $47.89 of Neurocrine Biosciences²¹
• May 29, 2024Sold 25,000 shares at $133.46 of Neurocrine Biosciences²¹
• May 29, 2024Exercised options 25,000 shares at $42.76 of Neurocrine Biosciences²¹
• May 17, 2024Exercised options 4,199 shares of Neurocrine Biosciences²²
• Nov 16, 2023Gift 2,750 shares of Neurocrine Biosciences²³
• Jun 26, 2023Granted 960 shares of Biogen²⁴
• Jan 3, 2023Sold 15,000 shares at $118.85 of Neurocrine Biosciences²⁵